Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Oncology Pubmed

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.

The Lancet Oncology , Volume 7 (9): 9 – Oct 10, 2006

Loading next page...
 
/lp/pubmed/adjuvant-vinorelbine-plus-cisplatin-versus-observation-in-patients-BZzxlKv4Jc

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1470-2045
DOI
10.1016/S1470-2045(06)70804-X
pmid
16945766

Abstract

Journal

The Lancet OncologyPubmed

Published: Oct 10, 2006

There are no references for this article.